“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says
In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco
NCI To Lose 19% of Workforce Over Six Years, Broder Says
NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion
NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes
Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines
Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines
DCPC To Merge Two Programs, Reorganizes Chemoprevention
Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval









